GlassScriptPhysician profile
Adam Bhatti
NPI 1689278541
$10,523.65
in general payments reported to CMS, 2019-2025
15 companies · $320 in 2025
The $320 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $867 · 2023: $4,696 · 2024: $4,641 · 2025: $320.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $6,212 · Food and Beverage: $3,445.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $6,211.69 |
| Food and Beverage | $3,445.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $5,874.76 | 2022-2024 | Prostep, Prophecy, Salvation |
| Orthofix Medical, INC. | $1,646.15 | 2024 | Truelok |
| Medical Device Business Services, INC. | $1,237.61 | 2024 | |
| Smith+Nephew, INC. | $478.10 | 2023-2024 | Osteoraptor, Firstpass, Q-Fix |
| Depuy Synthes Sales INC. | $308.16 | 2024 | Motoband, Na, Motoband Cp |
| Integra Lifesciences Corporation | $196.35 | 2023-2024 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Mimedx Group, INC. | $178.16 | 2025 | |
| Kerecis Limited | $170.07 | 2023-2025 | Kerecis Omega3 Surgiclose, Kerecis Surgiclose, Kerecis Omega3 Marigen |
| Treace Medical Concepts, INC. | $141.50 | 2024-2025 | |
| Paragon 28, INC. | $92.68 | 2023 | Additive Orthopedics |
| Vanda Pharmaceuticals INC. | $77.35 | 2024-2025 | Fanapt, Hetlioz |
| Bioventus LLC | $46.94 | 2025 | Exogen Ultrasound Bone Healing System |
| Teva Pharmaceuticals USA, INC. | $36.30 | 2024 | Uzedy |
| Paratek Pharmaceuticals, INC. | $24.19 | 2024 | Nuzyra |
| Organogenesis INC. | $15.33 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adam Bhatti listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.